Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9296 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9296 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD7411 |
Suspended |
0.8936 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8936 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8874 |
High Similarity |
NPD7075 |
Discontinued |
0.8873 |
High Similarity |
NPD1549 |
Phase 2 |
0.8859 |
High Similarity |
NPD6801 |
Discontinued |
0.88 |
High Similarity |
NPD7819 |
Suspended |
0.88 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD1510 |
Phase 2 |
0.8777 |
High Similarity |
NPD1240 |
Approved |
0.875 |
High Similarity |
NPD3750 |
Approved |
0.8732 |
High Similarity |
NPD2796 |
Approved |
0.8699 |
High Similarity |
NPD6799 |
Approved |
0.8681 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8681 |
High Similarity |
NPD1243 |
Approved |
0.8675 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8652 |
High Similarity |
NPD1607 |
Approved |
0.8618 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.86 |
High Similarity |
NPD4380 |
Phase 2 |
0.8571 |
High Similarity |
NPD1511 |
Approved |
0.8562 |
High Similarity |
NPD7768 |
Phase 2 |
0.8535 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD3749 |
Approved |
0.85 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD2313 |
Discontinued |
0.8483 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8456 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8431 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8425 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8406 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8403 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8403 |
Intermediate Similarity |
NPD3748 |
Approved |
0.84 |
Intermediate Similarity |
NPD920 |
Approved |
0.8387 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8377 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8369 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8366 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8345 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8345 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8273 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8267 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8267 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8264 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8261 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8248 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8188 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD3226 |
Approved |
0.816 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8146 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8137 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8099 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8071 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8069 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8069 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8027 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8014 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8014 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7987 |
Intermediate Similarity |
NPD919 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7927 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7919 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7911 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7892 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7881 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7879 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7844 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7831 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7785 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7736 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7688 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7676 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD943 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7619 |
Intermediate Similarity |
NPD411 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7616 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD5889 |
Approved |
0.761 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7606 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7584 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7584 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7571 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7554 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3764 |
Approved |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD17 |
Approved |
0.7458 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7458 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD7003 |
Approved |
0.741 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7355 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7324 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7184 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7184 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1470 |
Approved |
0.716 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD74 |
Approved |
0.7101 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7092
|
Intermediate Similarity |
NPD1241 |
Discontinued |